Literature DB >> 18285488

Plasmid-mediated qepA gene among Escherichia coli clinical isolates from Japan.

Kunikazu Yamane1, Jun-ichi Wachino, Satowa Suzuki, Yoshichika Arakawa.   

Abstract

Seven hundred fifty-one Escherichia coli clinical isolates collected from 140 Japanese hospitals between 2002 and 2006 were screened for the qepA and qnr genes. Two E. coli isolates (0.3%) harbored qepA, but no qnr was identified. The results suggested a low prevalence of E. coli harboring qepA or qnr in Japan.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18285488      PMCID: PMC2292543          DOI: 10.1128/AAC.01137-07

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  20 in total

1.  Detection of qnr in clinical isolates of Escherichia coli from Korea.

Authors:  Jin-Yong Jeong; Hyun Jung Yoon; Eun Sil Kim; Yoola Lee; Sang-Ho Choi; Nam Joong Kim; Jun Hee Woo; Yang Soo Kim
Journal:  Antimicrob Agents Chemother       Date:  2005-06       Impact factor: 5.191

2.  Detection of plasmid-mediated quinolone resistance associated with qnrA in an Escherichia coli clinical isolate producing CTX-M-9 beta-lactamase in Japan.

Authors:  Ryoichi Saito; Wakako Kumita; Kenya Sato; Toshio Chida; Noboru Okamura; Kyoji Moriya; Kazuhiko Koike
Journal:  Int J Antimicrob Agents       Date:  2007-01-18       Impact factor: 5.283

Review 3.  Analysis and construction of stable phenotypes in gram-negative bacteria with Tn5- and Tn10-derived minitransposons.

Authors:  V de Lorenzo; K N Timmis
Journal:  Methods Enzymol       Date:  1994       Impact factor: 1.600

4.  Quinolone resistance from a transferable plasmid.

Authors:  L Martínez-Martínez; A Pascual; G A Jacoby
Journal:  Lancet       Date:  1998-03-14       Impact factor: 79.321

Review 5.  The worldwide emergence of plasmid-mediated quinolone resistance.

Authors:  Ari Robicsek; George A Jacoby; David C Hooper
Journal:  Lancet Infect Dis       Date:  2006-10       Impact factor: 25.071

6.  Mechanism of plasmid-mediated quinolone resistance.

Authors:  John H Tran; George A Jacoby
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-09       Impact factor: 11.205

7.  16S ribosomal RNA methylation: emerging resistance mechanism against aminoglycosides.

Authors:  Yohei Doi; Yoshichika Arakawa
Journal:  Clin Infect Dis       Date:  2007-05-21       Impact factor: 9.079

8.  Plasmid-mediated quinolone resistance in clinical isolates of Escherichia coli from Shanghai, China.

Authors:  Minggui Wang; John H Tran; George A Jacoby; Yingyuan Zhang; Fu Wang; David C Hooper
Journal:  Antimicrob Agents Chemother       Date:  2003-07       Impact factor: 5.191

9.  New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate.

Authors:  Kunikazu Yamane; Jun-Ichi Wachino; Satowa Suzuki; Kouji Kimura; Naohiro Shibata; Haru Kato; Keigo Shibayama; Toshifumi Konda; Yoshichika Arakawa
Journal:  Antimicrob Agents Chemother       Date:  2007-06-04       Impact factor: 5.191

Review 10.  Emerging mechanisms of fluoroquinolone resistance.

Authors:  D C Hooper
Journal:  Emerg Infect Dis       Date:  2001 Mar-Apr       Impact factor: 6.883

View more
  69 in total

1.  Molecular epidemiology over an 11-year period (2000 to 2010) of extended-spectrum β-lactamase-producing Escherichia coli causing bacteremia in a centralized Canadian region.

Authors:  Gisele Peirano; Akke K van der Bij; Daniel B Gregson; Johann D D Pitout
Journal:  J Clin Microbiol       Date:  2011-12-07       Impact factor: 5.948

2.  Expression of multidrug efflux pump genes acrAB-tolC, mdfA, and norE in Escherichia coli clinical isolates as a function of fluoroquinolone and multidrug resistance.

Authors:  Michelle C Swick; Sonia K Morgan-Linnell; Kimberly M Carlson; Lynn Zechiedrich
Journal:  Antimicrob Agents Chemother       Date:  2010-11-22       Impact factor: 5.191

3.  Mechanisms of reduced susceptibility to ciprofloxacin in Escherichia coli isolates from Canadian hospitals.

Authors:  Patricia J Baudry-Simner; Amanpreet Singh; James A Karlowsky; Daryl J Hoban; George G Zhanel
Journal:  Can J Infect Dis Med Microbiol       Date:  2012       Impact factor: 2.471

4.  High level of quinolone resistance in Escherichia coli from healthy chicken broilers.

Authors:  V Kmet; M Kmetová
Journal:  Folia Microbiol (Praha)       Date:  2010-03-25       Impact factor: 2.099

5.  Plasmid-mediated quinolone resistance pump QepA2 in an Escherichia coli isolate from France.

Authors:  Vincent Cattoir; Laurent Poirel; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2008-07-21       Impact factor: 5.191

6.  High prevalence of plasmid-mediated quinolone resistance determinants qnr, aac(6')-Ib-cr, and qepA among ceftiofur-resistant Enterobacteriaceae isolates from companion and food-producing animals.

Authors:  Junying Ma; Zhenling Zeng; Zhangliu Chen; Xiaogang Xu; Xiaoying Wang; Yuting Deng; Dianhong Lü; Liangzong Huang; Yunyuan Zhang; Jianhua Liu; Minggui Wang
Journal:  Antimicrob Agents Chemother       Date:  2008-10-20       Impact factor: 5.191

7.  Characterization of the plasmid-borne quinolone resistance gene qnrB19 in Salmonella enterica serovar Typhimurium.

Authors:  Anna Maria Dionisi; Claudia Lucarelli; Slawomir Owczarek; Ida Luzzi; Laura Villa
Journal:  Antimicrob Agents Chemother       Date:  2009-06-15       Impact factor: 5.191

Review 8.  Non-phenotypic tests to detect and characterize antibiotic resistance mechanisms in Enterobacteriaceae.

Authors:  Agnese Lupo; Krisztina M Papp-Wallace; Parham Sendi; Robert A Bonomo; Andrea Endimiani
Journal:  Diagn Microbiol Infect Dis       Date:  2013-10-03       Impact factor: 2.803

9.  Constitutive SoxS expression in a fluoroquinolone-resistant strain with a truncated SoxR protein and identification of a new member of the marA-soxS-rob regulon, mdtG.

Authors:  Anna Fàbrega; Robert G Martin; Judah L Rosner; M Mar Tavio; Jordi Vila
Journal:  Antimicrob Agents Chemother       Date:  2009-12-14       Impact factor: 5.191

10.  Gram-negative bacteria that produce carbapenemases causing death attributed to recent foreign hospitalization.

Authors:  Jasmine Ahmed-Bentley; A Uma Chandran; A Mark Joffe; Desiree French; Gisele Peirano; Johann D D Pitout
Journal:  Antimicrob Agents Chemother       Date:  2013-04-22       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.